Mechanism of neutrophil dysfunction by plasmodium falciparum secreted histidine-rich protein II people with malaria infection caused by plasmodium falciparum are significantly more susceptible to…

Active Project Grant Awarded Last action

Award ID
R21AI185223
Recipient
Awarding agency
Obligated
$1,104,050

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 79% complete
Originally
Place of performance
St. Louis, MO 63110, USA

Award details come from USAspending.gov.

Description

Mechanism of neutrophil dysfunction by plasmodium falciparum secreted histidine-rich protein II people with malaria infection caused by plasmodium falciparum are significantly more susceptible to invasive bacterial infections during and in the weeks following acute malaria infection. Plasma from infected patients can modulate neutrophil function, a critical aspect of the immune response for controlling bacterial infection. Interestingly, neutrophils isolated from children with malaria have an impaired oxidative burst even at 4 weeks following malaria infection. Proposed models of neutrophil dysfunction suggest a role for heme induction of heme oxygenase 1, an enzyme known to reduce the production of reactive oxygen species in neutrophils by down- regulating expression of nadph oxidase subunits. However, heme does not remain elevated after malaria infection and does not explain the persistent neutrophil dysfunction. We propose a model that incorporates histidine-rich protein II (hrpii), an abundant secreted parasite protein that circulates as a nanoparticle. Notably, hrpii has a long half-life and persists in children with malaria for up to 4 weeks. We previously showed that heme-laden hrpii (hrpii:heme) delivers a high load of intracellular heme, inducing reactive oxygen species (ROS), inflammation, and cellular junction disruption in vascular endothelial cells and causes vascular leakage in mice. In preliminary studies using a model human neutrophil-like cell line (DHL60), we have found that hrpii:heme, unlike free heme, does not directly stimulate the oxidative burst. Pre-treatment with hrpii:heme prior to DHL60 stimulation with PMA results in decreased oxidative burst within a few minutes. IT also causes a slow but dramatic induction of heme oxygenase 1. The goal of this proposal is to identify the molecular mechanisms by which neutrophils sense hrpii:heme and the signaling pathways that are required to impair oxidative burst activity. Our first aim utilizes targeted molecular blockade in DHL60 cells of known pathways of hrpii cellular effects and neutrophil pathways involved in oxidative burst signaling. Our second aim will utilize an unbiased approach with transcriptome profiling (RNA-SEQ) of DHL60 treated with hrpii and a genome-wide crispr/CAS9 knockout screen to determine genes essential for hrpii effects. The proposed work will provide insight into how hrpii affects neutrophils and, in time, potential therapeutics to prevent invasive bacterial infections in patients with malaria.

Transactions

Action Obligated Date
Amendment $0
Amendment $194,375
Amendment $0
Amendment $0
Amendment $23,325
Amendment $23,325
Amendment $23,325
Amendment $209,925
Amendment $209,925
Amendment $209,925
Original award $209,925
Show all 11

Quick answers

Who received award R21AI185223?

R21AI185223 was awarded to The Washington University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 22, 2024.

How much is award R21AI185223 worth?

$1,104,050 has been obligated on R21AI185223.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award